https://www.orthoworld.com
ORTHOWORLD
Vericel Posts 2Q18 MACI Revenue Growth
For 2Q18, Vericel posted MACI orthobiologic revenue of US $14.1MM, +9.3% vs. 2Q17, with 1H18 revenue of $26.2MM, +46.3% vs. 1H17.
Empowering Orthopaedic Executives through Strategic Intelligence
Product Labels: Orthobiologic Soft Tissue Repair
Tags: Revenue Report